Contact No: +91-8826373757 | +91-8826859373 | 011-25052216
Email: rakesh.its@gmail.com | editor@innovativepublication.com


Print ISSN:-2394-2789

Online ISSN:-2394-2797

CODEN : IJPCN9

Current Issue

Year 2019

Volume: 6 , Issue: 4

Article view: 401

Article download: 188

International Journal of Pharmaceutical Chemistry and Analysis


Bedaquiline –A new drug against multidrug-resistant tuberculosis


Full Text PDF Share on Facebook Share on Twitter


Author Details : Sankalp Yadav, Gautam Rawal

Volume : 5, Issue : 2, Year : 2018

Article Page : 106-107


Suggest article by email

Abstract

The infectious diseases have taken a toll on the rapidly multiplying population of the developing countries. The top three killers being HIV AIDS, TB and malaria. The total number of deaths due to TB is really a cause of concern since a well laid national program is running in most of these countries. However, even in the presence of clear guidelines to treat TB, there has always been a gradual rise in the new cases with few exceptions in some of these resource-constrained countries. The issue becomes graver when the problem of drug-resistant TB also comes into the picture. In the present article, the authors highlight the introduction of the new drug i.e., Bedaquiline in India to counter the problem of multidrug-resistant TB.

Keywords: Bedaquiline, Drug; Drug-resistant, TB; Tuberculosis

Doi : 10.18231/2394-2797.2018.0017

How to cite : Yadav S, Rawal G, Bedaquiline –A new drug against multidrug-resistant tuberculosis. Int J Pharm Chem Anal 2018;5(2):106-107

Copyright © 2018 by author(s) and Int J Pharm Chem Anal. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)